Craft

CURE Pharmaceutical

Stock Price

$2.3

2024-10-29

Market Capitalization

$104.7 M

2024-10-29

Revenue

$4.3 M

FY, 2023

CURE Pharmaceutical Summary

Company Summary

Overview
CURE Pharmaceutical is a drug delivery and development company. It utilizes a proprietary CUREform drug delivery platform, which includes CUREfilm, oral thin films, CUREpods, a chewable delivery system, and other traditional dose forms that use encapsulation technology. The company works with biotech, pharmaceutical, and wellness organizations.
Type
Public
Status
Active
Founded
2011
HQ
Oxnard, CA, US | view all locations
Website
https://www.curepharmaceutical.com/
Cybersecurity rating
Sectors

Key People

  • Ruben King-Shaw, Chairman of the Board

    LocationsView all

    1 location detected

    • Oxnard, CA HQ

      United States

      1620 Beacon Pl

    CURE Pharmaceutical Financials

    Summary Financials

    Revenue (Q3, 2024)
    $192.0K
    Gross profit (Q3, 2024)
    $157.0K
    Net income (Q3, 2024)
    ($541.0K)
    Cash (Q3, 2024)
    $11.0K
    EBIT (Q3, 2024)
    ($503.0K)
    Enterprise value
    $113.3M

    Footer menu